AVENUE THERAPEUTICS, INC. such as entering into a material definitive agreement, notice of disbarment, or breach of a continuing listing rule or standard; Transfer of Registration, Change of Directors or Principal Officers (Form 8-K)
Section 1.01 Entering into a Material Definitive Agreement.
If completed, the transaction should provide Baergic with better access to development financing. The valuation and negotiation of the Contribution Agreement was overseen and the execution of the Contribution Agreement was approved by special committees at the Avenue and Fortress levels, both composed exclusively of independent and disinterested directors of the boards of directors of the respective companies.
The summary of the Contribution Agreement presented above does not purport to be complete and is submitted and qualified in its entirety by reference to the text of the Contribution Agreement, a copy of which will be filed in a subsequent periodic report of the Company.
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or
Standard; Transfer of Listing.
Pursuant to Nasdaq Listing Rule 5605(c)(4), Nasdaq may grant the Company a relief period to restore compliance with Nasdaq Listing Rule 5605. As discussed in Section 5.02 of this Report current on the Form 8-K below, after the date of
Article 5.02 Departure of directors or certain officers; Election of directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(formerly Gilda’s Club New York). She was recognized as a
© Edgar Online, source